Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Gains from Investment Securities (2023 - 2025)

Guardian Pharmacy Services' Gains from Investment Securities history spans 3 years, with the latest figure at $5.1 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 224.34% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $4.5 million, up 684.49%, while the annual FY2025 figure was $4.5 million, 684.49% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $5.1 million at Guardian Pharmacy Services, up from -$2.9 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $5.1 million in Q4 2025 and bottomed at -$4.1 million in Q4 2024.
  • The 3-year median for Gains from Investment Securities is $26000.0 (2024), against an average of $38000.0.
  • The largest YoY upside for Gains from Investment Securities was 2498.88% in 2025 against a maximum downside of 184.85% in 2025.
  • A 3-year view of Gains from Investment Securities shows it stood at -$3.4 million in 2023, then decreased by 20.81% to -$4.1 million in 2024, then skyrocketed by 224.34% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Gains from Investment Securities are $5.1 million (Q4 2025), -$2.9 million (Q3 2025), and $2.1 million (Q2 2025).